In our lab, we use bioinformatic approaches to make sense of cancer-omics data through developing several databases (DriverDB, YM500, SurvomicsDB) and a webtool (LipidSig). At the same time, we also cooperate with experimental biologists and medical scientists for specific topics, such as cancer immunology (Nat cell bio, 2017), cancer biomarkers (Theranostics, 2021; Molecular Therapy-Nucleic Acids, 2021), cancer stem cells (Int J Cancer 2019;Cancers, 2021), and bioinformatics tools development (Nat Methods, 2018). Lab website: http://chenglab.cmu.edu.tw/home/

醫學院癌症生物與藥物研發博士學位學程 教授/The Ph.D. Program for Cancer Biology and Drug Discovery Professor



  • 清華大學 生醫工程與環境科學所 博士
    National Tsing Hua University Doctor
  • 清華大學 生醫工程與環境科學所 碩士
    National Tsing Hua University Master
  • 中原大學 物理系 學士
    Chung Yuan Christian University Bachelor

經歷/Work experience

  • 中國醫藥大學 醫學院生物醫學研究所 副教授(1080801~1090731)
    China Medical University Graduate Institute of Biomedical Sciences Associate Professor
  • 中國醫藥大學 醫學院癌症生物與藥物研發博士學位學程 副教授(1090801~1110731)
    China Medical University Associate Professor
  • 中國醫藥大學 癌症生物與藥物研發博士學位學程 教授(1110801~)
    China Medical University Program for Cancer Biology and Drug Discovery Professor
  • 中國醫藥大學 醫學院癌症生物學研究所 助理教授(1040801~)
    China Medical University Graduate Institute of Cancer Biology Assistant Professor
  • 中國醫藥大學 腫瘤醫學研究中心 助研究員(1030801~1040731)
    China Medical University Research Center for Tumor Medical Science 助Researcher

主管經歷/Administrative experience

專長/Research expertise

  • Genomics
  • Bioinformatics
  • Next generation sequencing analysis
  • Biological database
  • Lipidomics